Corcept Therapeutics Inc CORT

NAS: CORT | ISIN: US2183521028 15/10/2025

76,81 USD (+6,50%)

(+6,50%) 15/10/2025

Grafiek Corcept Therapeutics Inc

Grafiek Corcept Therapeutics Inc

1 dag1d 6,50%
1 week1w -13,07%
1 maand1m 7,70%
3 maanden3m 5,44%
6 maanden6m 18,90%
1 jaar1j 62,49%
5 jaar5j 326,72%

Corcept Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

27 januari 2022 · Moore Kuehn, PLLC Encourages Investors of CORT and CACC to Contact Law Firm · Persbericht

15 maart 2021 · Corcept Therapeutics Initiates Phase 1b Trial of Relacorilant Plus Pembrolizumab (Keytruda®) in Patients with Adrenal Cancer with Cortisol Excess · Persbericht

23 februari 2021 · Corcept Therapeutics Announces Fourth Quarter and Full-Year 2020 Audited Financial Results · Persbericht

8 februari 2021 · Corcept Therapeutics Announces Fourth Quarter, Full-Year 2020 Preliminary Selected Financial Results and 2021 Revenue Guidance; Provides Corporate Update · Persbericht

1 februari 2021 · Corcept Therapeutics to Announce Preliminary Selected Financial Results, Provide Corporate Update and Host Conference Call · Persbericht

Profiel Corcept Therapeutics Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Website: www.corcept.com

Hoofdzetel: Menlo Park, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe